Analyzing the options chain and the chart patterns of RDUS Radius Recycling prior to the earnings report this week, I would consider purchasing the 17.5usd strike price Puts with an expiration date of 2024-9-20, for a premium of approximately $1.15. If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
Endo International plc (NASDAQ: ENDP) announced today that one of its operating companies, Par Pharmaceutical, Inc. (Par), has begun shipping the first authorized generic versions of Mallinckrodt's Amitiza® (lubiprostone) 8 mcg and 24 mcg capsules. According to IQVIA™, Amitiza® capsule sales were approximately $427 million for the 12 months ended September 30,...
RDUS still maintains analyst buys/PT of >60 wth their new approved drug, Tymlos which will start selling later this year (hopefully) and has strong advantages over current Forteo. Nevertheless, the market wayyyy overreacted to news of a new CEO & look at the RSI now! I just wrote Jan 2018 35 puts and about to write July & Aug. 40s for easy premium or cheap shares...
Huge volatility contractions recently with all good news and a near break to the upside. The range on this guy is massive, with impulses showing roughly $48 target on first and mid $50's target on the second. Extremely bullish on this name.
Watch for a breakout to the upside of the wedge, and wait for it to hit the first profit target. Take half off there, and wait for it to hit the second profit target. Price Target 3 is based on long term fundamentals
This stock is building a base watch for break above 50.09 then if volume supports move then look for long with potential 25-40% target use good stop and risk management